Literature DB >> 19680007

A case of abrupt onset autoimmune type 1 diabetes mimicking fulminant type 1 diabetes.

Shinya Makino1, Sumio Hamada, Masanobu Iwata, Masayoshi Fujiwara.   

Abstract

A 63-year-old male was admitted to our hospital with diabetic ketoacidosis. He had flu-like symptoms 10 days before admission and developed thirst, polyuria and anorexia with 9 kg of body weight loss in a week. Plasma glucose level on admission was 983 mg/dL and HbA1c was 7.5%. Despite high levels of serum pancreatic enzymes, lack of severe abdominal pain and no morphological change of pancreas in the abdominal CT scan eliminated the complication of classical acute pancreatitis. These findings suggested the diagnosis of fulminant type 1 diabetes. However, urinary and plasma C-peptide levels showed that insulin secretion was not completely depleted at onset. Furthermore, an examination of islet-related antibodies revealed the presence of high titer anti-GAD antibody. His HLA typing showed that DRB1*0901-DQB1*0303 and A24 were present. He has been doing well with continuation of insulin therapy. Over two years after onset, his plasma C-peptide level was gradually lowered, and anti-GAD antibody was still positive. Taken together, this is a rare case of abrupt onset autoimmune type 1 diabetes with transient but apparent exocrine pancreatic impairment at onset. Similar cases should be accumulated to clarify pathophysiological similarities and/or differences between fulminant type 1 diabetes and abrupt onset autoimmune type 1 diabetes.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19680007     DOI: 10.1507/endocrj.k09e-074

Source DB:  PubMed          Journal:  Endocr J        ISSN: 0918-8959            Impact factor:   2.349


  4 in total

1.  Elevated pancreatic enzymes, IgM, soluble interleukin-2 receptor in anti-GADab(+) type 1 diabetes.

Authors:  Hidekatsu Yanai; Sumie Moriyama
Journal:  World J Diabetes       Date:  2011-05-15

2.  Evaluating the Immunopathogenesis of Diabetes After Acute Pancreatitis in the Diabetes RElated to Acute Pancreatitis and Its Mechanisms Study: From the Type 1 Diabetes in Acute Pancreatitis Consortium.

Authors:  Anna Casu; Paul J Grippo; Clive Wasserfall; Zhaoli Sun; Peter S Linsley; Jessica A Hamerman; Brian T Fife; Adam Lacy-Hulbert; Frederico G S Toledo; Phil A Hart; Georgios I Papachristou; Melena D Bellin; Dhiraj Yadav; Maren R Laughlin; Mark O Goodarzi; Cate Speake
Journal:  Pancreas       Date:  2022-07-01       Impact factor: 3.243

3.  Non-autoimmune acute-onset type 1 diabetes mellitus newly developed in an elderly patient presenting elevation of serum pancreatic exocrine enzymes.

Authors:  Akinori Kanzaki; Morihiro Matsuda; Shinji Yokota; Kenji Takai; Jun Murai; Akihito Otsuka; Hidenori Koyama; Tadashi Nakamura
Journal:  Diabetol Int       Date:  2021-08-26

4.  The clinical utility of comprehensive measurement of autoimmune disease-related antibodies in patients with advanced solid tumors receiving immune checkpoint inhibitors: a retrospective study.

Authors:  N Izawa; H Shiokawa; R Onuki; K Hamaji; K Morikawa; H Saji; H Ohashi; S Kasugai; N Hayakawa; T Ohara; Y Sunakawa
Journal:  ESMO Open       Date:  2022-03-02
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.